
MPW Valuation
Medical Properties Trust Inc
- Overview
- Forecast
- Valuation
- Earnings
MPW Relative Valuation
MPW's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MPW is overvalued; if below, it's undervalued.
Historical Valuation
Medical Properties Trust Inc (MPW) is now in the Fair zone, suggesting that its current forward PS ratio of 2.80 is considered Fairly compared with the five-year average of 12.76. The fair price of Medical Properties Trust Inc (MPW) is between 4.37 to 10.04 according to relative valuation methord.
Relative Value
Fair Zone
4.37-10.04
Current Price:4.38
Fair
69.17
PE
1Y
3Y
5Y
Trailing
Forward
14.41
EV/EBITDA
Medical Properties Trust Inc. (MPW) has a current EV/EBITDA of 14.41. The 5-year average EV/EBITDA is 14.33. The thresholds are as follows: Strongly Undervalued below 11.65, Undervalued between 11.65 and 12.99, Fairly Valued between 15.67 and 12.99, Overvalued between 15.67 and 17.01, and Strongly Overvalued above 17.01. The current Forward EV/EBITDA of 14.41 falls within the Historic Trend Line -Fairly Valued range.
22.98
EV/EBIT
Medical Properties Trust Inc. (MPW) has a current EV/EBIT of 22.98. The 5-year average EV/EBIT is 21.31. The thresholds are as follows: Strongly Undervalued below 13.47, Undervalued between 13.47 and 17.39, Fairly Valued between 25.23 and 17.39, Overvalued between 25.23 and 29.16, and Strongly Overvalued above 29.16. The current Forward EV/EBIT of 22.98 falls within the Historic Trend Line -Fairly Valued range.
2.80
PS
Medical Properties Trust Inc. (MPW) has a current PS of 2.80. The 5-year average PS is 5.20. The thresholds are as follows: Strongly Undervalued below 0.66, Undervalued between 0.66 and 2.93, Fairly Valued between 7.48 and 2.93, Overvalued between 7.48 and 9.75, and Strongly Overvalued above 9.75. The current Forward PS of 2.80 falls within the Undervalued range.
0.00
P/OCF
Medical Properties Trust Inc. (MPW) has a current P/OCF of 0.00. The 5-year average P/OCF is 5.66. The thresholds are as follows: Strongly Undervalued below -3.32, Undervalued between -3.32 and 1.17, Fairly Valued between 10.15 and 1.17, Overvalued between 10.15 and 14.64, and Strongly Overvalued above 14.64. The current Forward P/OCF of 0.00 falls within the Undervalued range.
0.00
P/FCF
Medical Properties Trust Inc. (MPW) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Medical Properties Trust Inc (MPW) has a current Price-to-Book (P/B) ratio of 0.57. Compared to its 3-year average P/B ratio of 0.56 , the current P/B ratio is approximately 2.33% higher. Relative to its 5-year average P/B ratio of 0.92, the current P/B ratio is about -38.45% higher. Medical Properties Trust Inc (MPW) has a Forward Free Cash Flow (FCF) yield of approximately 6.29%. Compared to its 3-year average FCF yield of 13.48%, the current FCF yield is approximately -53.34% lower. Relative to its 5-year average FCF yield of 10.42% , the current FCF yield is about -39.64% lower.
0.57
P/B
Median3y
0.56
Median5y
0.92
6.29
FCF Yield
Median3y
13.48
Median5y
10.42
Competitors Valuation Multiple
The average P/S ratio for MPW's competitors is 1.93, providing a benchmark for relative valuation. Medical Properties Trust Inc Corp (MPW) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -17.51%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MPW increased by 8.64% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.78 to -1.63.
The secondary factor is the Revenue Growth, contributed -17.51%to the performance.
Overall, the performance of MPW in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

KWR
Quaker Chemical Corp
143.910
USD
-0.64%

RPD
Rapid7 Inc
20.140
USD
-0.15%

HNI
HNI Corp
44.730
USD
+0.65%

WULF
Terawulf Inc
9.240
USD
+3.47%

ADUS
Addus Homecare Corp
114.150
USD
-2.14%

SPNT
Siriuspoint Ltd
18.290
USD
-0.71%

FBK
FB Financial Corp
53.520
USD
+1.13%

MTX
Minerals Technologies Inc
63.740
USD
-0.36%

ARWR
Arrowhead Pharmaceuticals Inc
21.180
USD
+2.27%

ICFI
ICF International Inc
98.940
USD
+0.21%
FAQ

Is Medical Properties Trust Inc (MPW) currently overvalued or undervalued?
Medical Properties Trust Inc (MPW) is now in the Fair zone, suggesting that its current forward PS ratio of 2.80 is considered Fairly compared with the five-year average of 12.76. The fair price of Medical Properties Trust Inc (MPW) is between 4.37 to 10.04 according to relative valuation methord.

What is Medical Properties Trust Inc (MPW) fair value?

How does MPW's valuation metrics compare to the industry average?

What is the current P/B ratio for Medical Properties Trust Inc (MPW) as of Aug 27 2025?

What is the current FCF Yield for Medical Properties Trust Inc (MPW) as of Aug 27 2025?

What is the current Forward P/E ratio for Medical Properties Trust Inc (MPW) as of Aug 27 2025?
